Type II interleukin-1 receptor expression is reduced in monocytes/macrophages and atherosclerotic lesions-Reference-Cited by-同舟云学术

Type II interleukin-1 receptor expression is reduced in monocytes/macrophages and atherosclerotic lesions

Published:2011-09 Issue:9 Volume:1811 Page:556-563
ISSN:1388-1981
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids

Author:

Pou Jordi,Martínez-González José,Rebollo Alba,Rodríguez Cristina,Rodríguez-Calvo Ricardo,Martín-Fuentes Paula,Cenarro Ana,Civeira Fernando,Laguna Juan C.,Alegret Marta

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology

Reference38 articles.

1. Interleukins in atherosclerosis: molecular pathways and therapeutic potential;von der Thusen;Pharmacol. Rev.,2003

2. Differential effects of interleukin-1 receptor antagonist and tumor necrosis factor binding protein on fatty-streak formation in apolipoprotein E-deficient mice;Elhage;Circulation,1998

3. Immunological and inflammatory functions of the interleukin-1 family;Dinarello;Annu. Rev. Immunol.,2009

4. The membrane form of the type II IL-1 receptor accounts for inhibitory function;Neumann;J. Immunol.,2000

5. Monocyte gene-expression profile in men with familial combined hyperlipidemia and its modification by atorvastatin treatment;Llaverias;Pharmacogenomics,2008

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Negative regulator IL-1 receptor 2 (IL-1R2) and its roles in immune regulation of autoimmune diseases;International Immunopharmacology;2024-07

2. IL-1 Receptor Dynamics in Immune Cells: Orchestrating Immune Precision and Balance;Immune Network;2024

3. Relationships among gut microbes, the interleukin family, and hypertension: a mediation Mendelian randomization study;Frontiers in Nutrition;2023-11-28

4. Single-cell analysis reveals novel clonally expanded monocytes associated with IL1β–IL1R2 pair in acute inflammatory demyelinating polyneuropathy;Scientific Reports;2023-04-11

5. Oridonin employs interleukin 1 receptor type 2 to treat noise-induced hearing loss by blocking inner ear inflammation;Biochemical Pharmacology;2023-04